Pistacia khinjuk
Pistacia khinjuk · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Pistacia khinjuk is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Research has highlighted its potent antibacterial and cytotoxic activities, making it a subject of intense medicinal study. Various preparations, including aqueous, methanol, and oleo gum resin extracts, are utilized to isolate its bioactive compounds. These extracts are being investigated for their ability to combat complex conditions such as cancer, HIV, and metastasis. Furthermore, the plant shows promise in modulating critical biological processes like angiogenesis.
- Synonyms
- Pistacia Acuminata · Pistacia Khinjuk Var. Glaberrima · 5 more
- Common names
- Not available
- Family
- Anacardiaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Pistacia khinjuk is a fascinating species known by a variety of diverse regional names. In many local areas, it is commonly referred to simply as Buttum. Its identity is also recognized internationally through terms such as Фисташка хинджук and the Hebrew אלה פרסית. Within Arabic-speaking communities, the plant is identified as either بطم أخضر or بطم كينجوك. These linguistic variations highlight the widespread cultural importance and geographic reach of this unique tree.
Sources: Catalogue of Life (COL)
Synonyms
Pistacia khinjuk is a complex species characterized by a variety of botanical synonyms that reflect its diverse classifications. In many taxonomic records, it is identified under the name Pistacia acuminata. The plant also encompasses several distinct varieties, including Pistacia khinjuk var. glaberrima and Pistacia khinjuk var. glabra. Furthermore, researchers recognize the variations known as Pistacia khinjuk var. heterophylla and Pistacia khinjuk var. microphylla. Understanding these nomenclatural relationships is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Pistacia khinjuk is a unique botanical specimen that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Sapindales, showcasing its specific evolutionary lineage. As a member of the genus Pistacia, it shares close biological ties with several other well-known plants. Finally, this species is distinguished by its placement within the Anacardiaceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Anacardiaceae |
| Genus | Pistacia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Pistacia khinjuk is a versatile species with an expansive geographic range spanning across two continents. In Africa, it can be found throughout Northern Africa in Egypt as well as within the Northeast Tropical regions of Sudan and South Sudan. Its presence extends significantly into the temperate zones of Asia, where it thrives across diverse landscapes. Specifically, the plant is established in Western Asia within Afghanistan and reaches into Central Asia in Tajikistan. Furthermore, its distribution encompasses the Arabian Peninsula, notably within the borders of Saudi Arabia.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Pistacia khinjuk grows in the form of a robust tree. This species is a self-supporting plant that stands firmly on its own within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Pistacia khinjuk has demonstrated significant therapeutic potential through its inherent biological activities. Research into gum nanoparticles derived from this plant has revealed effective antibacterial performance against strains such as Pseudomonas aeruginosa and Staphylococcus aureus. Furthermore, studies indicate that both the pure gum and its nanoparticle forms exhibit notable cytotoxic activity against various cell lines, including MCF7 and HT29. When evaluating oleoresin methanol extracts, the plant also showed cytotoxic effects against the Y79 cancer cell line. These combined properties suggest that Pistacia khinjuk could serve as an attractive natural component for future drug delivery and anticancer research.
Compounds
Conditions
Pistacia khinjuk demonstrates significant therapeutic potential by inhibiting the replication of HIV in vitro. The plant's extracts also exhibit antiangiogenic effects, which can help prevent the metastasis of cancer. Research indicates that its components can effectively treat cancer through these targeted biological actions. Additionally, the plant displays notable antibacterial activity against specific bacterial strains like Pseudomonas aeruginosa and Staphylococcus aureus. Finally, Pistacia khinjuk possesses inherent cytotoxicity that can be utilized in the development of novel drug delivery nanoparticles.
Preparations
Pistacia khinjuk is prepared as aqueous extracts to estimate total phenolic content, antioxidant potential, and larvicidal activity against Aedes aegyptii. The plant is also prepared as methanol extracts for similar investigations into its chemical properties and biological activities. In studies regarding anti-HIV potential, Pistacia khinjuk is utilized in the form of general extracts to inhibit viral replication. Furthermore, the species is prepared as oleo gum resin extracts to evaluate its cytotoxic and antiangiogenic effects. Specifically, these studies involve the use of oleoresin methanol extracts of Pistacia khinjuk to examine its impact on cancer cell lines and blood vessel formation.